Hancock Jaffe Laboratories, Inc. (HJLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

7.30-0.59 (-7.48%)

As of 3:37PM EST. Market open.

Loading interactive chart...

ACCESSWIRE
First U.S. Patent Allowed on Hancock Jaffe VenoValve
Company Receives Notice of Allowance from U. Patent and Trademark Office IRVINE, CA / ACCESSWIRE / February 24, 2021 / Hancock Jaffe Laboratories, Inc.
ACCESSWIRE
Hancock Jaffe Completes $41 Million Public Offering
Capital Raise to Fund VenoValve U. Pivotal TrialIRVINE, CA / ACCESSWIRE / February 11, 2021 / Hancock Jaffe Laboratories, Inc.
ACCESSWIRE
Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering
IRVINE, CA / ACCESSWIRE / February 9, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of its upsized underwritten public offering of units for gross proceeds of approximately $36 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the company.